One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Cell Dissociation Market

細胞解離市場ー業界洞察、主要プレーヤー・企業別、成長機会別、最新傾向別、開発別、主要な成長ドライバー別、主要な課題別によってセグメンテーション、予測 2023年


[ 英語タイトル ] Cell Dissociation Market by Product (Enzymatic (Collagenase, Trypsin, DNase, Elastase) Non-enzymatic), Type (Tissue Dissociation), Tissue (Connective, Epithelial), End User (Pharmaceutical, Research Institutes) - Global Forecast to 2023


Product Code : MNMHC00109568
Survey : MarketsandMarkets
Publish On : June, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

The key players in the cell dissociation market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).

[Report Description]

“The global cell dissociation market is projected to grow at a CAGR of 12.8% during the forecast period”
The cell dissociation market is expected to reach USD 440.5 million by 2023 from USD 241.2 million in 2018, at a CAGR of 12.8%. Factors driving the growth of this market include rising government funding for chronic disease research and increasing R&D investment in pharmaceutical & biotechnology companies. On the other hand, emerging economies such as China, India, and Brazil are providing lucrative opportunities for the players operating in the cell dissociation market.
“The non-enzymatic products segment is anticipated to grow at the fastest rate in the next five years”
Based on product, the market is segmented into enzymatic dissociation products, non-enzymatic dissociation products, and instruments & accessories market. Among all, the non-enzymatic product segment is estimated to grow at the highest CAGR during the forecast period. This can be primarily attributed to advantages such as ready to use and non-toxic in nature.
“Tissue dissociation type segment is expected to dominate the cell dissociation market during the forecast period”
On the basis of type, the market is segmented into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzymatic products and instruments & accessories in the pharmaceutical & biotechnology companies is the major driving factor for this segment.
“Asia Pacific is estimated to grow at the highest CAGR during the study period”
Geographically, the cell dissociation market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the fastest rate due to infrastructural developments in the life sciences industry, rising government investments for chronic disease research, and presence of emerging economies such as China and India.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1–35%, Tier 2–22% and Tier 3- 43%
• By Designation: C level–15%, Director level–32%, Others–53%
• By Region: North America–34%, Europe–25%, Asia Pacific–23%, Rest of the World–18%

The key players in the cell dissociation market include Thermo Fisher Scientific (US), Merck KGaA (Germany), Roche (Switzerland), Miltenyi Biotec (Germany), HiMedia Laboratories (India), STEMCELL Technologies (Canada), BD (US), ATCC (US), PAN-Biotech (Germany), and GE Healthcare (US).

Research Coverage:
The report analyses the cell dissociation market by product, tissue, type, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful.
Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one or a combination of the below mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the cell dissociation market
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the cell dissociation market
• Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the cell dissociation market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell dissociation products across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell dissociation market

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 MARKET SCOPE 12
1.3.1 MARKETS COVERED 12
1.3.2 YEARS CONSIDERED FOR THE STUDY 13
1.4 CURRENCY 13
1.5 LIMITATIONS 13
1.6 STAKEHOLDERS 13
2 RESEARCH METHODOLOGY 14
2.1 RESEARCH DATA 15
2.1.1 SECONDARY DATA 15
2.1.1.1 Key data from secondary sources 15
2.1.2 PRIMARY DATA 16
2.1.2.1 Key data from primary sources 17
2.2 MARKET SIZE ESTIMATION 17
2.2.1 BOTTOM-UP APPROACH 18
2.2.2 TOP-DOWN APPROACH 18
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 19
2.4 ASSUMPTIONS FOR THE STUDY 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 26
4.1 CELL DISSOCIATION MARKET OVERVIEW 26
4.2 ASIA PACIFIC: CELL DISSOCIATION MARKET, BY PRODUCT & COUNTRY 27
4.3 CELL DISSOCIATION MARKET, BY REGION 28
4.4 GEOGRAPHICAL SNAPSHOT OF THE CELL DISSOCIATION MARKET (MAJOR COUNTRIES) 29
5 MARKET OVERVIEW 30
5.1 INTRODUCTION 30
5.2 MARKET DYNAMICS 30
5.2.1 DRIVERS 31
5.2.1.1 Increasing R&D activities in biopharmaceutical companies 31
5.2.1.2 Favorable funding scenario for cancer research 31
5.2.2 OPPORTUNITY 32
5.2.2.1 Growth opportunities in emerging markets 32
5.2.3 TRENDS 32
5.2.3.1 Emergence of advanced tissue dissociation enzyme products 32
5.2.3.2 Acceptance of enzyme-free dissociation products over enzymatic dissociation products 33
6 CELL DISSOCIATION MARKET, BY PRODUCT 34
6.1 INTRODUCTION 35
6.2 ENZYMATIC DISSOCIATION PRODUCTS 36
6.2.1 COLLAGENASE 36
6.2.2 TRYPSIN 37
6.2.3 PAPAIN 38
6.2.4 ELASTASE 39
6.2.5 DNASE 40
6.2.6 HYALURONIDASE 41
6.2.7 OTHER ENZYMES 42
6.3 NON-ENZYMATIC DISSOCIATION PRODUCTS 43
6.4 INSTRUMENTS & ACCESSORIES 45
7 CELL DISSOCIATION MARKET, BY TISSUE TYPE 46
7.1 INTRODUCTION 47
7.2 CONNECTIVE TISSUE 48
7.3 EPITHELIAL TISSUE 49
7.4 OTHER TISSUE 50
8 CELL DISSOCIATION MARKET, BY APPLICATION 51
8.1 INTRODUCTION 52
8.2 TISSUE DISSOCIATION 52
8.3 CELL DETACHMENT 53
9 CELL DISSOCIATION MARKET, BY END USER 54
9.1 INTRODUCTION 55
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 56
9.3 RESEARCH & ACADEMIC INSTITUTES 57
9.4 OTHER END USERS 59
10 CELL DISSOCIATION MARKET, BY REGION 61
10.1 INTRODUCTION 62
10.2 NORTH AMERICA 63
10.2.1 US 66
10.2.2 CANADA 68
10.3 EUROPE 70
10.4 ASIA PACIFIC 72
10.4.1 JAPAN 75
10.4.2 CHINA 77
10.4.3 INDIA 78
10.4.4 REST OF ASIA PACIFIC 80
10.5 REST OF THE WORLD 82
11 COMPETITIVE LANDSCAPE 84
11.1 OVERVIEW 84
11.2 MARKET RANKING ANALYSIS 85
11.3 COMPETITIVE SCENARIO 86
11.3.1 EXPANSIONS 86
11.3.2 ACQUISITIONS 86
11.3.3 AGREEMENTS 86
12 COMPANY PROFILES 87
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 BD 87
12.2 THERMO FISHER SCIENTIFIC 89
12.3 F. HOFFMANN-LA ROCHE LTD. 91
12.4 GE HEALTHCARE 93
12.5 MERCK KGAA 95
12.6 ATCC 98
12.7 HIMEDIA LABORATORIES 99
12.8 PAN-BIOTECH 100
12.9 MILTENYI BIOTEC 101
12.10 STEMCELL TECHNOLOGIES 102

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 104
13.1 INSIGHTS OF INDUSTRY EXPERTS 104
13.2 DISCUSSION GUIDE 105
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 108
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 110
13.5 AVAILABLE CUSTOMIZATIONS 112
13.6 RELATED REPORTS 113
13.7 AUTHOR DETAILS 114

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+